Blockade of glucose-6-phosphate dehydrogenase induces immunogenic cell death and accelerates immunotherapy

Background Enhanced glucose metabolism has been reported in many cancers. Glucose-6-phosphate dehydrogenase (G6PD) is a rate-limiting enzyme involved in the pentose phosphate pathway, which maintains NADPH levels and protects cells from oxidative damage. We recently found that low G6PD expression co...

Full description

Saved in:
Bibliographic Details
Main Authors: Akimichi Morita, Hiroshi Kato, Motoki Nakamura, Maki Yoshimitsu, Tetsuya Magara, Katsuhiro Okuda, Keisuke Yokota, Shinji Kano
Format: Article
Language:English
Published: BMJ Publishing Group 2024-07-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/12/7/e008441.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items